| Paul Victor Polishuk, MD | |
|
215 S Hickory St, Suite 114, Escondido, CA 92025-4359 | |
| (760) 743-5111 | |
| (858) 429-7934 |
| Full Name | Paul Victor Polishuk |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 31 Years |
| Location | 215 S Hickory St, Escondido, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487648754 | NPI | - | NPPES |
| 00G843090 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | G84309 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mammoth Hospital | Mammoth lakes, CA | Hospital |
| Pomerado Hospital | Poway, CA | Hospital |
| Palomar Health Downtown Campus | Escondido, CA | Hospital |
| Northern Inyo Hospital | Bishop, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Graybill Medical Group Inc | 9335050517 | 104 |
| Southern Mono Health Care District | 9830002401 | 65 |
| Arch Health Partners Inc | 9931239027 | 221 |
News Archive
Mutations in the KRAS gene have long been known to cause cancer, and about one third of solid tumors have KRAS mutations or mutations in the KRAS pathway. KRAS promotes cancer formation not only by driving cell growth and division, but also by turning off protective tumor suppressor genes, which normally limit uncontrolled cell growth and cause damaged cells to self-destruct.
It may soon be possible to manage the serious condition of diabetes naturally using nutmeg seeds (Myristica fragrans) according to new research presented today at the British Pharmaceutical Conference in Manchester.
CD44 is recognised as an important cell surface receptor involved in the adhesion of circulating leukocytes to endothelium, a process that is critical for their trafficking in the vasculature. Now, a Japanese group of researchers using an ultra-sensitive Andor Neo sCMOS camera in their correlative microscopy set-up has demonstrated that microvilli projections around the cell surface mediate this adhesion.
Additional research is needed before laser therapy can be recommended as a treatment for acne, according to a study in the June 16 issue of the Journal of the American Medical Association (JAMA).
Compugen Ltd., a leading predictive drug discovery company, today presented new data for its preclinical CGEN-15029 program demonstrating the potential for the development of new cancer immunotherapy treatments for solid tumors, including the potential for drug combination with current immune checkpoint blockers.
› Verified 8 days ago
| Entity Name | Southern Mono Health Care District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962444059 PECOS PAC ID: 9830002401 Enrollment ID: O20031118001160 |
News Archive
Mutations in the KRAS gene have long been known to cause cancer, and about one third of solid tumors have KRAS mutations or mutations in the KRAS pathway. KRAS promotes cancer formation not only by driving cell growth and division, but also by turning off protective tumor suppressor genes, which normally limit uncontrolled cell growth and cause damaged cells to self-destruct.
It may soon be possible to manage the serious condition of diabetes naturally using nutmeg seeds (Myristica fragrans) according to new research presented today at the British Pharmaceutical Conference in Manchester.
CD44 is recognised as an important cell surface receptor involved in the adhesion of circulating leukocytes to endothelium, a process that is critical for their trafficking in the vasculature. Now, a Japanese group of researchers using an ultra-sensitive Andor Neo sCMOS camera in their correlative microscopy set-up has demonstrated that microvilli projections around the cell surface mediate this adhesion.
Additional research is needed before laser therapy can be recommended as a treatment for acne, according to a study in the June 16 issue of the Journal of the American Medical Association (JAMA).
Compugen Ltd., a leading predictive drug discovery company, today presented new data for its preclinical CGEN-15029 program demonstrating the potential for the development of new cancer immunotherapy treatments for solid tumors, including the potential for drug combination with current immune checkpoint blockers.
› Verified 8 days ago
| Entity Name | Graybill Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891729745 PECOS PAC ID: 9335050517 Enrollment ID: O20040108000857 |
News Archive
Mutations in the KRAS gene have long been known to cause cancer, and about one third of solid tumors have KRAS mutations or mutations in the KRAS pathway. KRAS promotes cancer formation not only by driving cell growth and division, but also by turning off protective tumor suppressor genes, which normally limit uncontrolled cell growth and cause damaged cells to self-destruct.
It may soon be possible to manage the serious condition of diabetes naturally using nutmeg seeds (Myristica fragrans) according to new research presented today at the British Pharmaceutical Conference in Manchester.
CD44 is recognised as an important cell surface receptor involved in the adhesion of circulating leukocytes to endothelium, a process that is critical for their trafficking in the vasculature. Now, a Japanese group of researchers using an ultra-sensitive Andor Neo sCMOS camera in their correlative microscopy set-up has demonstrated that microvilli projections around the cell surface mediate this adhesion.
Additional research is needed before laser therapy can be recommended as a treatment for acne, according to a study in the June 16 issue of the Journal of the American Medical Association (JAMA).
Compugen Ltd., a leading predictive drug discovery company, today presented new data for its preclinical CGEN-15029 program demonstrating the potential for the development of new cancer immunotherapy treatments for solid tumors, including the potential for drug combination with current immune checkpoint blockers.
› Verified 8 days ago
| Entity Name | Arch Health Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649500141 PECOS PAC ID: 9931239027 Enrollment ID: O20100616000715 |
News Archive
Mutations in the KRAS gene have long been known to cause cancer, and about one third of solid tumors have KRAS mutations or mutations in the KRAS pathway. KRAS promotes cancer formation not only by driving cell growth and division, but also by turning off protective tumor suppressor genes, which normally limit uncontrolled cell growth and cause damaged cells to self-destruct.
It may soon be possible to manage the serious condition of diabetes naturally using nutmeg seeds (Myristica fragrans) according to new research presented today at the British Pharmaceutical Conference in Manchester.
CD44 is recognised as an important cell surface receptor involved in the adhesion of circulating leukocytes to endothelium, a process that is critical for their trafficking in the vasculature. Now, a Japanese group of researchers using an ultra-sensitive Andor Neo sCMOS camera in their correlative microscopy set-up has demonstrated that microvilli projections around the cell surface mediate this adhesion.
Additional research is needed before laser therapy can be recommended as a treatment for acne, according to a study in the June 16 issue of the Journal of the American Medical Association (JAMA).
Compugen Ltd., a leading predictive drug discovery company, today presented new data for its preclinical CGEN-15029 program demonstrating the potential for the development of new cancer immunotherapy treatments for solid tumors, including the potential for drug combination with current immune checkpoint blockers.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul Victor Polishuk, MD 332 S Juniper St Ste 100, Escondido, CA 92025-4941 Ph: (760) 291-6621 | Paul Victor Polishuk, MD 215 S Hickory St, Suite 114, Escondido, CA 92025-4359 Ph: (760) 743-5111 |
News Archive
Mutations in the KRAS gene have long been known to cause cancer, and about one third of solid tumors have KRAS mutations or mutations in the KRAS pathway. KRAS promotes cancer formation not only by driving cell growth and division, but also by turning off protective tumor suppressor genes, which normally limit uncontrolled cell growth and cause damaged cells to self-destruct.
It may soon be possible to manage the serious condition of diabetes naturally using nutmeg seeds (Myristica fragrans) according to new research presented today at the British Pharmaceutical Conference in Manchester.
CD44 is recognised as an important cell surface receptor involved in the adhesion of circulating leukocytes to endothelium, a process that is critical for their trafficking in the vasculature. Now, a Japanese group of researchers using an ultra-sensitive Andor Neo sCMOS camera in their correlative microscopy set-up has demonstrated that microvilli projections around the cell surface mediate this adhesion.
Additional research is needed before laser therapy can be recommended as a treatment for acne, according to a study in the June 16 issue of the Journal of the American Medical Association (JAMA).
Compugen Ltd., a leading predictive drug discovery company, today presented new data for its preclinical CGEN-15029 program demonstrating the potential for the development of new cancer immunotherapy treatments for solid tumors, including the potential for drug combination with current immune checkpoint blockers.
› Verified 8 days ago
Dr. Philip C Bosch, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 651 E Pennsylvania Ave, Ste 201, Escondido, CA 92025 Phone: 760-743-3135 Fax: 760-743-7424 | |
Julian N. Anthony, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1955 Citracado Pkwy Ste 200, Escondido, CA 92029 Phone: 760-743-4789 Fax: 858-673-5187 | |
Dr. Thomas Allyn Jones, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 215 S Hickory St, Suite 114, Escondido, CA 92025 Phone: 760-743-5111 Fax: 858-429-7934 | |
Dr. Snaford Behrens, MD Urology Medicare: Medicare Enrolled Practice Location: 255 N Elm St, Escondido, CA 92025 Phone: 858-245-3368 |